Survival Analysis of Advanced HCC Treated with Radioembolization: Comparing Impact of Clinical Performance Status Versus Vascular Invasion/Metastases

[1]  W. Lau.  Commentary on the article entitled "hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation". , 2017, Hepatobiliary surgery and nutrition.

[2]  R. Salem,et al.  Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma , 2016, Advances in Therapy.

[3]  J. Boehm,et al.  Age and cancer risk: a potentially modifiable relationship. , 2014, American journal of preventive medicine.

[4]  D. Ganger,et al.  Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials. , 2013, Journal of vascular and interventional radiology : JVIR.

[5]  Carlo Morosi,et al.  Yttrium‐90 radioembolization for intermediate‐advanced hepatocellular carcinoma: A phase 2 study , 2013, Hepatology.

[6]  A. Santoro,et al.  Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial , 2009, Expert review of anticancer therapy.

[7]  Dieter Häussinger,et al.  Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.

[8]  Kenneth G. Thurston,et al.  Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. , 2006, Journal of vascular and interventional radiology : JVIR.

[9]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[10]  Yoon-Koo Kang,et al.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. , 2009, The Lancet. Oncology.

[11]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.